Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancerEmer O Hanrahan, Anderson J Ryan, Helen Mann, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
SroA links SigS-dependent stress signaling to metabolic remodeling in Staphylococcus aureusShahad Alqahtani, Sagar Pasham, Jamilah Alsulami, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|May 4, 2018
Cheap labor: myosin fiber type expression and enzyme activity in the forelimb musculature of sloths (Pilosa: Xenarthra)Kyle B Spainhower, Rebecca N Cliffe, Allan K Metz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii studyRonald B Natale, David Bodkin, Ramaswamy Govindan, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Genomic and Phenotypic Characterization of Mupirocin Resistant Staphylococcus aureus Clinical IsolatesAriana M Virgillio, Emily A Felton, Jessica K Jackson, et al.Open Forum Infectious Diseases|July 23, 2025
Genomic and Phenotypic Characterization of Mupirocin-resistant Staphylococcus aureus Clinical IsolatesAriana M Virgillio, Emily A Felton, Jessica K Jackson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancerJohn V Heymach, Bruce E Johnson, Diane Prager, et al.Journal of Bacteriology|May 31, 2023
Staphylococcus aureus SigS Induces Expression of a Regulatory Protein Pair That Modulates Its mRNA StabilityAmer Al Ali, Jamilah Alsulami, Joseph I Aubee, et al.The Lancet. Oncology|June 24, 2010
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trialRoy S Herbst, Yan Sun, Wilfried E E Eberhardt, et al.Pageof 2